From Pulse 2.0 · Amit Chowdhry · · 1m
Charta Health Raises $55M for AI Medical Chart Review
Charta Health secured $55 million in Series B funding to boost AI-driven medical chart accuracy and billing standards.
In brief
Charta Health secured $55 million in Series B funding to boost AI-driven medical chart accuracy and billing standards. Charta Health raised $55 million in Series B funding to expand AI medical chart review and billing accuracy for healthcare providers and insurers. Originally reported by Pulse 2.0.
Funding Round
Charta Health raised $55 million in Series B funding to expand its artificial intelligence platform for medical chart review and create a common standard of billing accuracy for healthcare providers and insurers.
Investors
Insight Partners led the round, with participation from existing investors Madrona, Bain Capital Ventures, and South Park Commons, along with QuantumLight.
AI Platform
Charta applies AI to unstructured clinical information, including physician notes, scanned orders, laboratory results, and images.
Key Benefit
The company says its platform produces consistent double-digit reductions in denial rates and gives compliance teams information about documentation gaps.
The bottom line
Charta Health raised $55 million in Series B funding to expand AI medical chart review and billing accuracy for healthcare providers and insurers.
